Does Medicaid Cover Ketamine for Depression in Virginia?
· Updated November 2026 · Aazaz Haq, MD
When someone with Virginia Medicaid asks me about ketamine, I give them the honest answer first: Medicaid generally does not cover IV or IM ketamine for depression, but it does cover Spravato, the FDA-approved form. For many people, that difference decides the plan.
The short answer
Virginia Medicaid generally does not cover IV or IM ketamine for depression, because it is used off-label. It does cover Spravato, the FDA-approved esketamine nasal spray, for adults who qualify, usually after prior authorization. For most people with Medicaid, Spravato is the practical route to a ketamine-based treatment.
Why ketamine is not covered
Ketamine was approved as an anesthetic in 1970. Its antidepressant effect was discovered decades later, after it had become an inexpensive generic. No company paid for the large trials needed for an FDA approval for depression, so IV and IM ketamine are still used off-label. Insurers, including Medicaid, rarely pay for off-label treatments like this.
Why Spravato is covered
Spravato contains esketamine, one of ketamine's two mirror-image forms. It went through full FDA trials and was approved in 2019 for treatment-resistant depression and in 2020 for depression with suicidal thoughts. Because it is FDA-approved, many insurers cover it, including Virginia Medicaid.
Coverage usually requires prior authorization showing that you have tried at least two antidepressants without enough improvement, and that treatment will happen at a certified center with two hours of monitoring after each dose. I explain the details in Is Spravato Covered by Medicaid in Virginia?
Other plans we accept
Many commercial plans also cover Spravato when their criteria are met. The plans we accept are listed on our insurance page. Coverage varies by plan; our insurance team checks your benefits, handles the prior authorization, and emails you your expected costs before you start.
If you want ketamine anyway
Some people prefer IV or IM ketamine, for example because it may work somewhat faster. At our clinic it is $400 per treatment, and we offer payment plans. We discuss the cost openly before anyone starts.
Who qualifies for Spravato
Spravato is approved for adults with major depressive disorder who have not done well on at least two antidepressants, and for adults with depression and active suicidal thoughts. Whether it is right for you is decided during a psychiatric evaluation.
To find out what your plan covers, request a consultation call.
Questions I hear often
Will Medicaid ever cover IV ketamine?
It would take either an FDA approval for depression, which is unlikely for an inexpensive generic, or a change in coverage policy. I would not count on it in the near term.
Is Spravato as good as IV ketamine?
The comparative evidence is mostly observational. One 2025 study suggested IV ketamine may work somewhat faster, but both treatments helped, and Spravato has the advantage of insurance coverage and FDA approval. For many people on Medicaid, Spravato is the most practical path to a ketamine-based treatment.
What does Spravato cost me on Medicaid?
Usually very little out of pocket once prior authorization is approved. Our team confirms your costs before you start.
What if I have Medicare too?
People with both Medicare and Medicaid can usually receive Spravato, with Medicare paying first. Our team sorts out the billing.
Other covered options
If Spravato is not a fit, TMS is FDA-cleared for depression and covered by Medicare and most commercial plans; our team can check whether your Medicaid plan covers it. Medication management is covered as well. The best plan is one you can actually start and complete, which is why we talk about coverage early rather than as an afterthought.
Our guide Will insurance cover it? shows how the approval process works.